The DIAPH1 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited human cell population featuring targeted disruption of the DIAPH1 gene in the HeLa host background. This polyclonal knockout model provides a heterogeneous pool of cells harboring diverse loss-of-function mutations across the DIAPH1 locus, enabling robust and reproducible analysis of DIAPH1-dependent biological processes without the clonal selection biases inherent in monoclonal lines. The product serves as a versatile platform for investigating the roles of the diaphanous-related formin 1 in actin cytoskeleton organization, cell adhesion, migration, and cytokinesis, and is suitable for a wide range of functional assays in biomedical research.
The host HeLa cell line is an immortalized human cervical carcinoma line derived from an epithelial adenocarcinoma of a 31-year-old female. HeLa cells exhibit robust proliferation, high transfection efficiency, and well-characterized cytoskeletal dynamics, making them an ideal chassis for studying actin regulatory mechanisms. Their constitutive activation of growth signaling and migratory propensity provide a physiologically relevant backdrop for examining DIAPH1 function in processes commonly dysregulated in metastatic cancers.
DIAPH1 encodes a formin protein that acts as a critical effector of Rho family GTPases, including RhoA, Rac1, and Cdc42. Upon activation by RhoA, DIAPH1 promotes nucleation and linear polymerization of actin filaments, driving the formation of stress fibers and the maturation of focal adhesion complexes. This activity is tightly coupled to upstream signals from integrins and serum response factor (SRF), as well as to downstream effectors such as the SRF/MAL transcriptional co-activator complex. DIAPH1 also interfaces with microtubule acetylation pathways via interactions with CLIP-170 and APC, and its activity is modulated by phosphatidylinositol 4,5-bisphosphate (PIP2), profilin, IQGAP1, and SRC kinase. Disruption of DIAPH1 therefore impedes the RhoA-to-actin signaling axis, compromising cytoskeletal remodeling essential for cell locomotion and division.
In the HeLa context, DIAPH1 knockout generates a profound impairment of actin-based structures. The resulting reduction in stress fibers and focal adhesions leads to defects in cell-substrate attachment, lamellipodial dynamics, and directional migration??hallmarks of cancer cell invasion. Moreover, disruption of DIAPH1-dependent cytokinetic rings yields multinucleated cells, mirroring phenotypes observed in Seckel syndrome and microcephaly. This model thus provides a tractable system for dissecting the molecular underpinnings of autosomal dominant deafness DFNA1, for exploring tumor cell dissemination, and for evaluating cytoskeletal-targeted therapeutics in a high-throughput-compatible format.
Researchers can employ these DIAPH1 knockout polyclonal cells in a variety of experimental workflows. Immunofluorescence staining permits visualization of residual F-actin architectures and focal adhesion components, while Western blotting confirms DIAPH1 ablation and monitors Rho pathway protein expression. Transwell invasion and migration assays quantify functional consequences on cell motility, and Rho GTPase activity pull-downs assess upstream signaling. Co-immunoprecipitation studies further delineate DIAPH1 interaction networks with actin, profilin, or IQGAP1. For additional technical specifications or to discuss custom applications, please contact Ascent Research.
